Catalyst Wire Dossier Catalyst Wire Dossier

R-EPOCH regimen

rituximab-etoposide-prednisone-vincristine-doxorubicin-cyclophosphamide regimen
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for R-EPOCH regimen, covering 2017-11-20 to 2017-11-20. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of Alisertib + R-EPOCH for Treatment of Myc-Positive Aggressive B-cell Lymphomas [Phase 1]

See pricing